Hematology, Oncology and Transplantation Fellowship Program
The Program Director for the Fellowship Training Program in Hematology, Medical Oncology, and Transplantation is Ariela Marshall, MD. The major goal of the Fellowship Training Program is to train physicians for independent and productive academic or clinical careers. We have two career tracks within the fellowship. The traditional hematology/oncology track leads to dual-board eligibility in hematology and medical oncology and emphasizes clinical training in all areas of hematology, oncology, and transplantation. The other fellowship track provides focused training in classical hematology and is supported by a grant from the American Society of Hematology. Both fellowship tracks are three years and include training to develop the skills needed for a successful academic career in basic or clinical/population outcomes research. Both tracks are also flexible and customized according to the needs and interests of the individual fellow.
During training, fellows select hematology/oncology faculty to work with, and act as mentors, in areas of their clinical and research interests. Read our faculty's research interests.
- Eligibility Requirements
- Application Process
- Traditional Hematology/Oncology
- Classical Hematology
- Clinical Path
- Research Path
To be eligible for consideration, applicants must have:
- Completion or anticipated completion of an ACGME-accredited (US) Internal Medicine or Med-Peds residency program prior to fellowship
- US citizenship, permanent resident status, or a J-1 visa.
- Visa Sponsorship: The J-1 alien physician visa sponsored by ECFMG is the preferred visa status for foreign national trainees in all UMN graduate medical education programs; therefore, the Endocrine Fellowship
- Program sponsors only J-1 visas. We do not sponsor H-1B visas. More information.
- Passed USMLE Steps I and II (and III if completed)
We will begin accepting applications for the 2026-2027 academic year, beginning July 16, 2025. Our interview period will run from September-October 2025.
| IMPORTANT DATES | STEPS IN APPLICATION PROCESS |
| July 7, 2025 | Applications can begin being submitted electronically |
| July 21, 2025 | Deadline for receipt of completed application |
| Sept.- Oct. 2025 | Interviews conducted, applications evaluated |
| November 2025 | Rank order list certification deadline |
| December 2025 | Match results released |
| July 1, 2026 | Start of fellowship |
How to Apply
The Fellowship Training Program accepts applications only through the Electronic Residency Application Service (ERAS) and offers positions through the National Resident Matching Program (NRMP). Once your completed application has been reviewed, we will contact you regarding its status and the possibility of a visit to our institution for interviews with the program's faculty.
The ERAS application must include the following:
- Personal statement that includes your background, education and experience, long-term goals, and areas of interest
- Current curriculum vitae
- Medical school transcript
- Three letters of recommendation
- A valid ECFMG certificate (if you graduated from a medical school outside the United States or Canada). Graduates who are not United States Citizens or permanent residents must obtain a J-1 Visa from the Education Commission on Foreign Medical Graduates (ECFMG) to qualify for a fellowship at the University of Minnesota
- USMLE Transcript
- Photo
Program Signaling
Our Fellowship Program has opted-in to receive program signals from applicants in the 2025 application season. Participating Hematology/Oncology programs are utilizing a two-tier signaling system this year, with (5) Gold and (15) Silver signals.
All students should signal programs if interested. This includes programs where students may have done visiting rotations or programs affiliated with students’ own medical schools. This promotes equity for those who do not have “home” programs.
We will preferentially review applications from those who signal our program, but will also consider applicants who do not signal us.
The Associate Program Director for the traditional hematology/oncology track is Manish Patel, DO. The goal of this track is to train fellows for careers in hematology and oncology. After the successful completion of training, each fellow will be eligible for both the hematology and oncology board exams. Within this track, fellows may choose to train broadly or to develop a more focused clinical and research expertise in any area of hematology, oncology, or stem cell transplantation. Applicants interested in classical (non-malignant) hematology are welcome to apply to both the traditional and classical hematology tracks. Applicants interested in a career in malignant hematology or stem cell transplantation/cellular therapies (e.g., CAR T-cell therapy) should apply only to the traditional track.
Year 1: Clinical Training
The goal of the first year of the training program is to provide a creative clinical environment for the fellow to develop skills and experience in the comprehensive care of cancer patients and in the diagnosis and management of hematologic diseases. The fellow will rotate on a monthly basis to clinical services at the University of Minnesota Medical Center (UMMC), Hennepin County Medical Center (HCMC), Regions Hospital, and the Veterans Administration Medical Center (VAMC). Fellows will receive a broad exposure to all aspects of hematology, oncology, and stem cell transplantation during their first year. Each fellow will be assigned a longitudinal clinic at the VAMC or HCMC.
Year 2‐3: Research and Clinical Training
During the first year of fellowship, each fellow will identify at least three mentors to serve on a career development committee and to assist the fellow in developing a career development plan to support their goals for the 2nd and 3rd years of training. Depending on project goals, clinical interests, and grant funding, the fellow will have 3-9 months of research time per year in their 2nd and 3rd years. There are competitive T32 research training funds in hematology, oncology, or health disparities available for which fellows can apply. Each fellow has the flexibility to train for a career in basic science/translational research, clinical or education research, and/or clinical care. Each fellow will participate in at least one half-day continuity care clinic throughout fellowship.
The Associate Program Director for the classical hematology track is Alexander Boucher, MD. The training leads to board eligibility in hematology and is supported by a Hematology-Focused Fellowship Training Program grant awarded by the American Society of Hematology, the only academic center in the upper Midwest with this type of funding. The overall goal of this track is to train physicians for careers in classical hematology, such as sickle cell disease and thalassemias, other congenital anemias, autoimmune hemolytic anemia and thrombocytopenia, bleeding and clotting disorders, and general consultative hematology. Fellows will have a unique opportunity to learn novel lifespan care models for adolescent and young adult hematologic disorders. Under the leadership of Dr. Boucher, this track will emphasize lifespan care of patients with hemoglobinopathies as well as bleeding and clotting disorders, with a particular focus in adolescent/young adult hematology transitions of care. Fellows will have opportunities to work closely with colleagues in other specialties, including interventional radiology, transfusion medicine, pediatrics/transitional care, and special coagulation laboratories, all of whom are already close collaborators for our complex hematology patients. Only applicants interested in life-long subspecialty careers focused on academic, multidisciplinary, classical (non-malignant) hematology should apply.
While fellows will receive the necessary training in hematologic malignancies to receive hematology board certification, the primary focus of the classical hematology track is rooted in a comprehensive, innovative, and multidisciplinary curriculum in non-malignant hematological diseases. Those applicants interested in careers in hematologic malignancies or stem cell transplantation/cellular therapies (e.g., CAR T-cell therapies) should apply for the traditional hematology/oncology track.
Year 1: Clinical Training
All fellows will spend their first year in general hematology. The goal of the first year of the training program is to provide a creative clinical environment for the fellow to develop skills and experience in the comprehensive care of patients with hematologic disorders. The fellow will rotate on a monthly basis to clinical services at the University of Minnesota Medical Center (UMMC), Hennepin County Medical Center (HCMC), and Regions Hospital. Fellows will receive a broad exposure to all aspects of hematology during their first year. This will include bleeding and clotting disorders, anemia and hemoglobinopathies, autoimmune hematologic disorders, malignant hematologic diseases, stem cell transplant, and CAR T-cell therapies. Fellows will learn to proficiently manage common disorders such as venous thromboembolism and iron deficiency anemia in an era of rapidly evolving evidence and treatment options requiring expert hematology guidance. Additionally, as one of the largest referral centers in the Midwest, fellows will gain early experience diagnosing and managing patients with rare disorders, such as paroxysmal nocturnal hemoglobinuria, porphyrias, other rare hemoglobinopathies and red cell enzymopathies, thrombotic thrombocytopenic purpura (TTP), and hereditary hemorrhagic telangiectasia. There is also limited exposure to solid tumor oncology to familiarize fellows with anti-neoplastic agents and hematologic complications of cancer.
Each fellow will be assigned a longitudinal clinic at HCMC or UMMC. Training includes rotations at the UMMC inpatient hematology consults, inpatient malignant hematology, inpatient stem cell transplant and cellular therapies service, and hematopathology, as well as inpatient and outpatient hematology rotations at HCMC. Fellows will also have exposure to general hematology/oncology at Regions Hospital and VAMC to understand the hematologic complications of non-hematologic malignancies. The general hematology continuity clinic will be at the M Health Clinics and Surgical Center.
Year 2‐3: Research and Clinical Training
During the first year of fellowship, each fellow will identify at least three mentors to serve on a career development committee to assist the fellow in developing a career development plan to support their goals for the 2nd and 3rd years of training. Depending on project goals and clinical interests, the fellow will have 3-9 months of research time per year in their 2nd and 3rd years. Each fellow has the flexibility to train for a career in basic science/translational research, clinical or education research, or clinical care. Each fellow will participate in classical hematology-focused rotations, such as hematology inpatient consults, outpatient clinic blocks at the Center for Bleeding and Clotting Disorders (CBCD), hematopathology, transfusion medicine, and vascular interventional radiology. Each fellow will participate in at least one half-day continuity care clinic throughout the 2nd and 3rd years. Fellows will be allowed a flexible schedule of research and hematology electives in two areas in lifespan hematology: 1) red cell disorders, cytopenias, and marrow failure and 2) hemostasis, thrombosis, and vascular medicine.
Fellows planning a career with the majority of time spent in clinical research and care of patients will focus on developing the skills to meet the individual fellow’s goals. The balance of time spent on research and clinical training is individualized to prepare each fellow for a career in an academic, academic-affiliated, or private practice setting as desired. Clinical skills of the trainee in the traditional hematology/oncology track are honed through broad exposure to classical hematology, hematologic malignancies, medical oncology, and stem cell transplantation. Those in the classical hematology track will be exposed to all aspects of hematology, with extra emphasis on non-malignant hematologic disorders. Training will also include education in enrolling and caring for patients on clinical trials and the completion of a scholarly activity or research project. Projects can include case reports, reviews, quality improvement projects, curriculum development, clinical outcomes research, epidemiology, and clinical trial development.
Clinical research and care milestones by the end of fellowship year 2 include the following:
- Present research or scholarly project at division conferences
- Attend a regional or national research meeting
- Present a poster presentation of research, quality improvement, or clinical case report at the annual Department of Medicine Research Day
- Complete 6-9 months of clinical training
Required milestones by the end of fellowship year 3 include the following:
- Submit one abstract to and attend a regional or national research meeting
- Present a poster presentation of research, quality improvement, or clinical case report at the annual Department of Medicine Research Day
- Write and submit one manuscript for publication.
- Complete 6-9 months of clinical training in areas related to clinical interests
For those interested in an academic career, a fourth training year composed of 12 months of research training may be considered, but is contingent upon performance and obtaining funding. Mentors will help guide these efforts for an application for a K award, an NRSA, or a foundation grant.
Fellows planning an academic career in which the majority of time is spent in research can focus on research training in clinical/population science research or laboratory/translational research. Fellows considering this option will typically have significant prior research experience. Fellows in the traditional hematology/oncology track with T32 support or individual grant support or fellows in the classical hematology track will have 18 months of dedicated research training (nine months each in years 2 and 3) and 18 months of clinical training (twelve months in year 1 and three months each in years 2 and 3). Clinical assignments will be based on the fellow’s progress in reaching required milestones. A fourth training year composed of 12 months of research training is strongly encouraged, but is contingent upon performance and obtaining funding.
Research intensive milestones by the end of fellowship year 2 include the following:
- Present research at division conferences
- Submit one abstract to and attend a national scientific meeting
- Present a poster at the annual Department of Medicine Research Day
- Complete 3 months of clinical training in areas related to research interests
Required milestones by the end of fellowship year 3 include the following:
- Submit one abstract to and attend a national scientific meeting
- Present a poster at the annual Department of Medicine Research Day
- Write and submit two manuscripts for publication
- Write and submit a career development grant application
Depending on circumstances, the career development grant application may be an application for a K award, an NRSA, or a foundation grant. Mentors will help guide these efforts. The final versions will be read and critiqued by the trainee’s career development committee.
Application Process
Timeline
We will begin accepting applications for the 2025-2026 academic year, beginning July 7, 2025. Our interview period will run from September-October 2025.
| IMPORTANT DATES | STEPS IN APPLICATION PROCESS |
| July 7, 2025 | Applications can begin being submitted electronically |
| July 21, 2025 | Deadline for receipt of completed application |
| Sept.- Oct. 2025 | Interviews conducted, applications evaluated |
| November 2025 | Rank order list certification deadline |
| December 2025 | Match results released |
| July 1, 2026 | Start of fellowship |
How to Apply
The Fellowship Training Program accepts applications only through the Electronic Residency Application Service (ERAS) and offers positions through the National Resident Matching Program (NRMP). Once your completed application has been reviewed, we will contact you regarding its status and the possibility of a visit to our institution for interviews with the program's faculty.
Program Signaling
Our Fellowship Program has opted-in to receive program signals from applicants in the 2025 application season. Participating Hematology/Oncology programs are utilizing a two-tier signaling system this year, with (5) Gold and (15) Silver signals.
All students should signal programs if interested. This includes programs where students may have done visiting rotations or programs affiliated with students’ own medical schools. This promotes equity for those who do not have “home” programs.
We will preferentially review applications from those who signal our program, but will also consider applicants who do not signal us.
VISA Policy
Visa Sponsorship: The J-1 alien physician visa sponsored by ECFMG is the preferred visa status for foreign national trainees in all UMN graduate medical education programs; therefore, the Hematology and Medical Oncology Fellowship sponsors only J-1 visas. We do not sponsor H-1B visas. More information can be found on the J-1 visas.
Current Fellows
First Year
Aditya Chauhan, MBBS
I was born and raised in India, where I completed my medical education at the Himalayan Institute of Medical Sciences. I pursued residency training at The Brooklyn Hospital Center, an affiliate of the Icahn School of Medicine at Mount Sinai in Brooklyn, New York and went on to complete my fellowship in Diabetes, Endocrinology, and Metabolism at the University of Minnesota where I also served as a chief Fellow. During medical school, I was deeply inspired by my experiences working with medical oncologists. I found it incredibly fulfilling to care for patients fighting some of the toughest battles of their lives. Having witnessed my mother’s own battle with cancer, I initially took a step back from oncology and chose to pursue endocrinology, focusing my clinical and research efforts on endocrine malignancies. Over the years, I have presented my work at national conferences including the Endocrine Society, ASCO, AACE, and the American Thyroid Association. I also have interests in clinical teaching, having been awarded as the best teacher award during my residency. However, through my residency and especially during my endocrine fellowship, I came to realize that my true calling lies in oncology. I have since pursued a fellowship in Hematology and Oncology, with clinical interests in head and neck tumors and neuroendocrine neoplasms. Outside of medicine, I enjoy running, going to the gym, playing cricket, and exploring the city.
Whitney Johnson, MD
Whitney Johnson grew up in Hastings, MN, and completed her undergraduate studies at the University of Wisconsin-Madison. She also spent a year as an English teaching assistant in Madrid, Spain, before returning to the University of Minnesota for medical school, residency, and a chief resident year. Her clinical interests span the full spectrum of hematology/oncology, with a focus on solid tumors. She is passionate about improving quality of life for patients with cancer and their caregivers, with research during residency focused on the time burdens of cancer care and geriatric chemotoxicity risk. She is also interested in the intersection of health care and policy. Outside of medicine, Whitney enjoys walking her dog by the many lakes in the Twin Cities, spending time with family and friends, traveling, and discovering new patios during Minnesota summers.
Sana Kagalwalla, MD
Dr. Sana Kagalwalla is originally from the Chicago suburbs. She attended medical school at the University of Pittsburgh and then completed residency in internal medicine at the University of Minnesota. In residency, her research focused on the time burdens experienced by patients with cancer and their caregivers. She has a particular interest in solid oncology as well as the overlap between oncology and palliative care. Outside of medicine, she enjoys traveling, hiking, reading, exploring new restaurants, and spending time with family.
Luke Kicklighter, MD
Dr. Luke Kicklighter grew up in Kansas and completed a BS in Microbiology at Kansas State University. During his undergraduate studies he developed an interest in oncology while participating in research studying the role of gap junctions in cancer as well as investigating targeted molecules to inhibit tumor angiogenesis. Afterwards he attended the Medical University of South Carolina where he found himself particularly drawn to hematologic malignancies, especially in the young adult population. Following this interest, he completed combined Internal Medicine and Pediatrics residency at Virginia Commonwealth University, during which he participated in retrospective AML research. Outside of his work in medicine he is an avid baseball fan, a budding roller coaster junkie, and a not-all-that-fast sailor.
Jenna Langer, MD
Jenna Langer is a Minnesota native, growing up in Long Prairie, Minnesota. She completed her undergraduate degrees in Biology and Spanish at the College of St. Scholastica in Duluth, Minnesota. She received her medical degree from the University of Minnesota and completed her internal medicine training there as well. She has participated in research on multiple myeloma and financial toxicity and has clinical and research interests in rural oncology. Outside of work, Jenna enjoys spending time with family, watching sports, going to the gym and being at the cabin.
Xiao Li, MD, PhD
Dr. Xiao Li was born and raised in China, where she earned her medical degree from Xi’an Jiaotong University. Driven by a deep passion for oncology, she went on to pursue a Ph.D. in cancer research, during which she had the opportunity to train at Emory University’s Winship Cancer Institute. She completed her internal medicine residency at St. Luke’s Hospital in Chesterfield, Missouri, where she was honored to serve as a peer-elected chief resident in her final year. Throughout residency, she remained actively involved in oncology research at Washington University in St. Louis. Dr. Li has a strong clinical and research interest in solid tumors and is inspired by the rapid advancements in cancer treatment. In her free time, she enjoys discovering great restaurants, exploring local parks, and spending time with her family.
Jacqueline Rios, MD
Dr. Jacqueline Rios completed her medical degree at Texas Tech University Health Sciences Center and internal medicine residency at Houston Methodist Hospital, where she developed a deep appreciation for both clinical complexity and diagnostic dilemmas. She was born in Monterrey, Mexico and grew up near Houston, Texas before following her heart to Minnesota. Dr. Rios discovered early on that her favorite part of medicine involved both complex pathology and getting to know people in their most human moments. As a first-generation American, she is passionate about improving care for underserved populations, increasing representation in medicine, and advocating for her patients at every step of their journey. Her academic interests include malignant hematology, CAR-T therapy, and survivorship. When she’s not discussing B-cell signaling pathways or explaining platelets to patients with creative metaphors, you can find her baking something experimental, dancing in her kitchen, or planning her next big trip with her husband—even if it’s just to the hospital gift shop.
Racquel Kaizer, MD
Second Year
Dr. Shubham Agrawal is from Gujarat, India and earned his medical degree from Surat Municipal Institute of Medical Education and Research in India. He completed his Internal Medicine residency at Mercy Catholic Medical Center in Pennsylvania. During his residency, he was a peer elected class representative. He was drawn to the field of hematology and oncology from his medical school with a particular interest in hemostasis and thrombosis. He is very passionate about addressing hematological care gaps across various health care delivery models in rural and urban areas. He aspires to be a systems based hematologist and has had oral and poster presentations at multiple national and international conferences such as ASCO, ISTH. During his free time, he enjoys improv comedy, biking and exploring local hikes and cooking for his friends and family.
Get to Know Dr. Agrawal in his interview for our Fellows in Focus series!
Dr. Sujan Badal was born and raised in Kathmandu, Nepal. He received his medical degree from the University of Minnesota and completed his residency at Washington State University. Prior to his medical education, he trained in basic science research at the Mayo Clinic studying protein-drug interactions, DNA/RNA aptamer design, and investigating the underlying biology of neuroendocrine tumors. Subsequently, in medical school he was selected as a Mescher scholar, where he participated in research involving checkpoint receptor (PD1) expression and function in immune (NK) cells. During residency, he was actively involved in general medicine and oncology research projects leading to several publications, conference invites, and selection as National Young Scholar in Internal Medicine by SGIM in 2024. His current clinical and research interests include hematological malignancies, immuno-oncology, and cellular therapies. Outside of work, he enjoys travel, hiking, exploring new restaurants, and spending time with friends and family.
Dr. Stijn Hentzen grew up in Des Moines, Iowa and received a B.S. in biochemistry at the University of Creighton in Omaha, Nebraska. Afterwards, he attended medical school at the University of Iowa where he graduated with distinctions in research and healthcare delivery science, management, and policy. He then completed his internal medicine residency training at The University of Kansas in Kansas City where he developed an interest in quality improvement, patient safety, and cancer survivorship research. Following the completion of residency, he stayed with the KU program as a chief resident and dedicated time to the mentorship of residents and the improvement of the residency training experience. Outside of work, Dr. Hentzen enjoys spending time with his family, trying to keep up with his two very busy toddlers, being outside, playing and watching sports, and skiing.
Dr. Milan Khealani earned his medical degree from Liaquat University of Medical & Health Sciences in Pakistan and completed a Master's in Sociology. He pursued his Internal Medicine residency at the Icahn School of Medicine at Mount Sinai, in New York City.
Following his residency, Dr. Khealani joined the Mayo Clinic Health System as a consultant in the Department of Hospital Medicine. In this role, he served as a floor medical director and led several leadership and quality improvement projects. His dedication to patient care earned him the Karis Award, which honors physicians who exemplify Mayo Clinic values and prioritize patient needs above all else. Additionally, he served as an assistant professor of medicine at Mayo Clinic.
Dr. Khealani has a special interest in solid oncology and has been deeply involved in research, with numerous publications in peer-reviewed journals. As a clinical preceptor and mentor, he is dedicated to educating and guiding residents and medical students.
Outside of medicine, Dr. Khealani enjoys yoga, listening to music, watching movies, gardening, and spending quality time with his family.
Dr. Alexander Paschke grew up in Madison, Wisconsin. Before medical school, he worked in medical informatics for the software company Epic at their headquarters in Wisconsin, leading projects at hospitals across the country. He then attended medical school at Western Michigan University in Kalamazoo, MI. He continued his tour of the midwest completing Internal Medicine Residency at the University of Iowa Hospitals & Clinics in Iowa City, IA. His research interests have included gastrointestinal and neuroendocrine tumors. He also is passionate about medical education. During residency, he notably developed and ran a day-long, hands-on simulation course for medical students to learn and practice end-of-life and palliative care skills. He places high value in the human side of medicine and has been recognized for it by patients and peers. Outside of medicine, he enjoys playing dad-rock guitar in his basement, kayaking, and spending time with his son.
Originally born in Venezuela, Dr. Rondon Rueda obtained her MD degree at Universidad de Ciencias Medicas (UCIMED) in Costa Rica. She subsequently completed her Internal Medicine residency at Hennepin Healthcare in Minneapolis, MN. From a very early stage in her training, she knew she wanted to help patients who suffered from oncologic disease. While in Costa Rica, she experienced the importance of access to novel treatments in cancer care and collaborated towards reviews of various immunotherapies and their impact for their inclusion in the Costa Rican healthcare system portfolio. From this point forward, her interest in learning more about solid organ malignancies and their therapies continued to grow, as did her drive for advocating for the Hispanic community to overcome barriers to screening, diagnosis and dignified oncologic care. Throughout her residency, she attended ACP, MSCO, and ITMIG conferences, wrote on thoracic malignancies and continues to do research on cancer health disparities and methods to enhance survival through early detection with particular interest in gastro-intestinal tumors. Outside of medicine, she enjoys exercise, visiting state parks, watching movies, reading novels, and exploring gastronomy from different cultures.
Dr. Abdulsabur Sanni is originally from Abuja Nigeria and earned his MD degree from the University of Debrecen in Hungary. He completed his Internal Medicine residency at Hennepin Helathcare, here in Minneapolis. He has known his medical journey would lead him to hematology and oncology since his second year of medical school and has interests in each area of the vast field. His benign heme interests include sickle cell disease, bleeding and clotting disorders with a special interest in pregnant persons. In malignant heme, he is interested in Myelodysolastic syndrome and Myeloprofoliferative neoplasms’s. His medical oncology interests include prostate cancer and neuro-oncology. He hopes to be a well-rounded hematologist and oncologist and aims to become a clinician educator. He has presented at national conferences like ASH, CHEST and ACP. Outside of medicine, he is an avid fan of Harry Potter and its lore, exploring regional cuisines and travelling. He joined the fellowship program in 2024.
Third Year
Nidhi Desai, MD
Nidhi Desai received her medical degree from Virginia Commonwealth University School of Medicine in Richmond, Virginia. She then completed her residency in Internal Medicine at the University of Minnesota. She has participated in research in quality of life and cancer survivorship in the field of oncology and has clinic and research interests in solid tumor oncology. Outside of work, she enjoys spending time outdoors, exploring new restaurants, painting, traveling, and spending time with family. |
Adrienne Kaufman, MD
Dr. Adrienne Kaufman is a Minnesota native, growing up in Falcon Heights, MN. She received a B.A. in biology at St. Olaf College, and then Master's of Science in medical physiology at Loyola University Chicago. From there, she went on to obtain her M.D. at Western Michigan University Homer Stryker M.D. School of Medicine, and completed Internal Medicine Residency at Mayo Clinic, in Arizona. Dr. Kaufman’s research/clinical practice areas of interest are in classical hematology, particularly thrombotic microangiopathies, but additionally an interest in lymphoma and myeloma. Outside of work, she enjoys cooking, travel, hiking, board games, spending time with family and friends, and exploring new places and things. |
David Kazadi, MD, PhD
Before moving to the Twin Cities, David Kazadi called New York City home. He received a Bachelor of Arts from Hunter College of the City University of New York, focusing on Biochemistry and Interdisciplinary Studies. Later, he joined the MD/PhD program at Columbia University College of Physicians & Surgeons. His doctoral work focused on genomic maintenance during immunoglobulin diversification processes in B lymphocytes. Now as a Fellow and a PSTP member, his interests include understanding and coöpting the immune system to control disease, particularly of neoplastic nature. |
Vrushali Pachpande, MS, MBBS
Dr. Vrushali Pachpande was born and raised in Thane, India where she received her medical degree from Rajiv Gandhi medical school. She then obtained MS in Cell and Molecular Biology from University of Houston with opportunities to learn and practice basic science research techniques. To pursue her interest in clinical medicine, she joined the Internal Medicine residency program at Guthrie/Robert Packer hospital in Sayre, PA where she also served as one of the chief residents in the final year of residency. She participated actively in patient safety and quality improvement activities. She was awarded ‘Best Resident of the Year’ in her final year of residency. Following graduation, she worked in the same hospital as an Associate in Internal Medicine, working closely with medical students and residents. She joins the classical hematology track of the program in 2023. Her interests include books, yoga, taking long walks and spending time with family and friends. |
Sujith Puskoor, DO
Dr. Sujith Puskoor grew up just west of Dallas, Texas. He completed his B.S. in biology, with a minor in business administration, at Texas A&M University before earning an M.S. in biomedical sciences at UNT Health Science Center. Afterwards, he attended medical school at Nova Southeastern University, where he was elected to the Sigma Sigma Phi honor society. Finally, he completed his Internal Medicine residency at Baylor Scott & White Medical Center. His passion for hematology/oncology first arose in high school and has continued to grow stronger throughout his medical career. Through his experiences, he developed a clinical interest in hematologic and solid tumor malignancies. He has presented at regional and national conferences, including ACC, ACP, ASCO, IMS, and CHEST. He feels grateful, humbled, and privileged to contribute to the care of patients in their time of need. Outside of medicine, he is a huge Dallas Cowboys and Dallas Mavericks fan. He enjoys traveling with his fiancée, hiking, kayaking, and playing fantasy football. Get to Know Dr. Puskoor in his interview for our Fellows in Focus series!
|
Program Director
Ariela Marshall, MD
Associate Professor
Associate Program Director
Manish Patel, DO
Associate Professor
Program Coordinator
Matt Boynton
[email protected]
612-626-0400
Clinic Contact
612-676-4200